Delivery Order SPE2DB25D3017-SPE2DB26FVGTY
- Not listed
- The Defense Logistics Agency awarded a $1,627.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CREXONT ER 87.5 MG-350 MG capsules (120-count supply) on December 5, 2025, with completion scheduled for December 8, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,030.34 to AmerisourceBergen Drug Corp for the supply of CREXONT ER 87.5 MG-350 MG capsules (120 count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, issued under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,231.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for CREXONT ER 70 mg-280 mg capsules (120-count supply). This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 28, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,851.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for CREXONT ER 87.5 MG-350 MG capsules (120-count supply). This non-set-aside competitive award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,379.61 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count). This non-set-aside, competitively awarded contract features firm fixed-price terms with an ultimate completion date of November 26, 2025. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,192.05 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 mg-350 mg capsules (120-count supply). This is a firm fixed-price delivery order with no set-aside designation, completed on September 3, 2025, and performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its...
- The Defense Logistics Agency awarded a $4,684.31 delivery order to AmerisourceBergen Drug Corp for Crexont ER 280 mg capsules (120 count) on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999...
- The Defense Logistics Agency awarded a $11.7K delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of CREXONT ER 52.5 MG-210 MG capsules (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of April 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,070.52 to AmerisourceBergen Drug Corp for Crexont ER 70 mg–280 mg capsules (120-count supply) on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order for pharmaceutical...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGTYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,966.32 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 mg–210 mg capsules (120 count). The contract, executed on October 27, 2025, with an ultimate completion date of October 28, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company serves military and veteran healthcare systems, the Defense Health Agency, and other government healthcare organizations through the comprehensive pharmaceutical prime vendor vehicle. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceuticals, generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. This individual delivery order represents a routine pharmaceutical procurement within that larger strategic contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 10/27/25 |